种系相关与散发性BAP1失活黑素细胞肿瘤的组织形态学谱系
该研究分析BAP1失活黑素细胞病变的组织形态学特征,比较种系突变与未知或阴性状态病例,发现形态学谱系广泛,种系突变病例更常见广泛交界成分,约12%的BIMT患者有种系突变,广泛交界受累及个人黑素瘤或BIMT史可能是种系检测的额外指征。
要点
- BAP1失活黑素细胞肿瘤形态学谱系广泛,包括梭形细胞样细胞(69%)、无梭形特征的小上皮样细胞(31%)和横纹肌样细胞特征(58%)。
- 种系突变患者的BIMT更常见广泛交界成分的BAP1失活黑素细胞(P = .0177)。
- 所有11例疑似或确诊种系突变患者均有皮肤黑素瘤或多个BIMT病史。
核心结论
- 约12%的BIMT患者有种系突变。
- BIMT中广泛交界受累以及个人黑素瘤或既往BIMT史可能是种系检测的额外指征。
研究设计与样本
- 分析BAP1失活黑素细胞病变的组织形态学特征,比较种系突变病例与未知或阴性状态病例,并报告可得的临床随访数据。
主要发现
- BAP1失活黑素细胞病变形态学谱系广泛,包括梭形细胞样细胞形态(69%)、无梭形特征的小上皮样细胞(31%)和横纹肌样细胞特征(58%)。
- 种系突变患者的BIMT更常见广泛交界成分的BAP1失活黑素细胞(P = .0177)。
- 所有11例疑似或确诊种系突变患者均有皮肤黑素瘤或多个BIMT病史。
临床怎么用
- 作者认为,BIMT中广泛交界受累以及个人黑素瘤或既往BIMT史可能是种系检测的额外指征。
局限性
- 77例患者种系状态未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: BRCA1-associated protein 1 (BAP1)-inactivated melanocytic tumors (BIMTs) are often the earliest sign of the BAP1 tumor predisposition syndrome. Identification of BIMTs and selection of patients for germline testing affect the lives of patients with germline BAP1 mutations. OBJECTIVE: To describe the spectrum of histomorphologic findings in BAP1-inactivated melanocytic lesions to improve their recognition. We determined the frequency of sporadic versus germline cases in our cohort, assessing whether any features were statistically linked to germline status. METHODS: Histomorphologic features of BAP1-inactivated melanocytic lesions were analyzed by comparing cases with germline mutations with those with unknown or negative status. Available clinical follow-up data were reported. RESULTS: The histomorphologic spectrum of BAP1-inactivated melanocytic lesions is broad; it includes cases with spitzoid cytomorphology (69%), smaller epithelioid cells without spitzoid features (31%), and rhabdoid cytologic features (58%). BIMTs from patients with germline mutations were statistically more likely to have an extensive junctional component of BAP1-inactivated melanocytes (P = .0177). All 11 patients with suspected or confirmed germline mutations had a history of cutaneous melanoma or multiple BIMTs. LIMITATIONS: The unknown germline status of 77 patients. CONCLUSION: Approximately 12% of patients with BIMTs have germline mutations. Extensive junctional involvement in a BIMT and a personal history of melanoma or previous BIMT may be additional indications for germline testing.
引用
- Garfield EM, Walton KE, Quan VL, et al. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors. J Am Acad Dermatol. 2018. PMID: 29753057. doi:10.1016/j.jaad.2018.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。